GlaxoSmithKline | GSK - Sales Revenues

Stock Price
1,925.25
Daily Change
48.75 2.60%
Monthly
5.75%
Yearly
37.67%
Q1 Forecast
1,839.16

GlaxoSmithKline reported GBP8.55B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
AbbVie USD 15.78B 360M Sep/2025
Alcon AG USD 2.59B 10M Sep/2025
Almirall EUR 560.46M 71.95M Jun/2025
Amgen USD 9.56B 380M Sep/2025
argenx SE USD 987.09M 144.59M Sep/2025
AstraZeneca USD 15.19B 733M Sep/2025
Bayer EUR 9.66B 1.08B Sep/2025
Biogen USD 2.53B 70M Sep/2025
Bristol-Myers Squibb USD 12.2B 70M Sep/2025
Eli Lilly USD 17.6B 2.04B Sep/2025
Fresenius EUR 5.48B 100M Sep/2025
Fresenius Medical Care EUR 4.89B 100M Sep/2025
Galapagos EUR 65.3M 4.87M Sep/2025
Genmab DKK 5.86B 580M Jun/2025
Gilead Sciences USD 7.8B 700M Sep/2025
GlaxoSmithKline GBP 8.55B 557M Sep/2025
Glaxosmithkline GBP 11.52B 3.54B Sep/2025
GRIFOLS EUR 1.87B 20M Sep/2025
Hikma Pharmaceutical USD 829M 758M Jun/2025
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.32B 890M Sep/2025
Merck USD 17.28B 1.47B Sep/2025
Novartis USD 13.91B 144M Sep/2025
Novo Nordisk DKK 76.86B 0 Sep/2025
Orion EUR 423.2M 6.7M Sep/2025
Pfizer USD 16.7B 2B Sep/2025
Philips EUR 4.3B 38M Sep/2025
Recordati EUR 624.35M 18.8M Sep/2025
Regeneron Pharmaceuticals USD 3.88B 130M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.3B 1.13B Dec/2025
Smith & Nephew USD 2.96B 134M Dec/2025
UCB EUR 3.49B 129M Jun/2025